DEFA14A: Acrivon Therapeutics Sets Date for Annual Stockholders Meeting
Proxy Statement
Acrivon Therapeutics will hold its annual meeting of stockholders on June 20, 2024, to elect directors and ratify the appointment of PricewaterhouseCoopers LLP as its independent accounting firm.
Summary
- Acrivon Therapeutics, Inc. will hold its annual meeting of stockholders on Thursday, June 20, 2024, at 11:00 AM Eastern Time.
- The meeting will be held live via the internet, and stockholders must register at www.proxydocs.com/ACRV to attend and participate.
- The proxy materials, including the notice of meeting, proxy statement, and annual report on Form 10-K, are available online at www.proxydocs.com/ACRV.
- Stockholders of record as of April 22, 2024, are eligible to vote.
- The agenda includes the election of three Class II directors: Kristina Masson, Ph.D., M.B.A., Sharon Shacham, Ph., M.B.A., and Ivana Magovcevic-Liebisch, Ph.D., J.D.
- Stockholders will also vote to ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
- Paper copies of the proxy materials can be requested until June 10, 2024, via internet, phone, or email.
Sentiment
Score: 5
Explanation: The document is a standard proxy statement, indicating a neutral sentiment.
Positives
- Stockholders have multiple options to access proxy materials and vote, including online, phone, and email.
- The company is adhering to SEC rules by making proxy materials available online.
Industry Context
This is a standard proxy filing related to the annual meeting of stockholders, a routine event for publicly traded companies.
Stakeholder Impact
- Shareholders are asked to vote on key company matters.
- The outcome of the votes will influence the company's direction and governance.
Next Steps
- Stockholders should review the proxy materials and vote on the proposals.
- The company will hold the annual meeting on June 20, 2024.
Key Dates
| Date | Description |
|---|---|
| April 22, 2024 | Record date for stockholders eligible to vote at the annual meeting. |
| June 10, 2024 | Deadline to request paper copies of proxy materials. |
| June 20, 2024 | Date of the Annual Meeting of Stockholders at 11:00 AM Eastern Time. |
| December 31, 2024 | Fiscal year end for which PricewaterhouseCoopers LLP's appointment is being ratified. |
Keywords
Annual Meeting, Proxy Statement, Stockholders, Acrivon Therapeutics, Directors, PricewaterhouseCoopers, Voting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.